Hält derzeit eine Position bei Evelo Biosciences Inc
Position | Company | Period |
---|---|---|
Chairman of the Board | Evelo Biosciences Inc | 17. September 2019 - |
Director | Evelo Biosciences Inc | 1. März 2017 - 17. September 2019 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2022-05-31 | 2022-05-27 |
Evelo Biosciences Inc
(EVLO)
|
K Kauf |
17.123
+25.6%
1,4625.000 USD |
17.123 +25.6% | 1,46 | 25.000 USD | |
2022-04-22 | 2022-04-21 |
Rubius Therapeutics Inc
(RUBY)
|
K Kauf |
30.000
+0.6%
1,4443.329 USD |
30.000 +0.6% | 1,44 | 43.329 USD | |
2022-03-18 | 2022-03-16 |
Axcella Health Inc
(AXLA)
|
K Kauf |
26.178
+19.4%
1,9150.000 USD |
26.178 +19.4% | 1,91 | 50.000 USD | |
2021-02-16 | 2021-02-11 |
Rubius Therapeutics Inc
(RUBY)
|
GV Geplanter Verkauf |
26.704
-0.6%
14,93398.560 USD |
26.704 -0.6% | 14,93 | 398.560 USD | |
2021-02-10 | 2021-02-10 |
Rubius Therapeutics Inc
(RUBY)
|
GV Geplanter Verkauf |
7.404
-0.2%
14,79109.525 USD |
7.404 -0.2% | 14,79 | 109.525 USD | |
2021-02-10 | 2021-02-09 |
Rubius Therapeutics Inc
(RUBY)
|
GV Geplanter Verkauf |
2.100
-0.0%
14,8331.146 USD |
2.100 -0.0% | 14,83 | 31.146 USD | |
2021-02-10 | 2021-02-08 |
Rubius Therapeutics Inc
(RUBY)
|
GV Geplanter Verkauf |
89.233
-1.9%
14,881.328.117 USD |
89.233 -1.9% | 14,88 | 1.328.117 USD | |
2020-12-14 | 2020-12-11 |
Evelo Biosciences Inc
(EVLO)
|
K Kauf |
200
+1.1%
7,021.404 USD |
200 +1.1% | 7,02 | 1.404 USD | |
2020-12-14 | 2020-12-11 |
Evelo Biosciences Inc
(EVLO)
|
K Kauf |
500
+2.9%
6,983.490 USD |
500 +2.9% | 6,98 | 3.490 USD | |
2020-12-14 | 2020-12-11 |
Evelo Biosciences Inc
(EVLO)
|
K Kauf |
1.000
+6.2%
6,916.910 USD |
1.000 +6.2% | 6,91 | 6.910 USD | |
2020-12-14 | 2020-12-11 |
Evelo Biosciences Inc
(EVLO)
|
K Kauf |
800
+5.3%
7,165.728 USD |
800 +5.3% | 7,16 | 5.728 USD | |
2020-12-14 | 2020-12-11 |
Evelo Biosciences Inc
(EVLO)
|
K Kauf |
4.970
+48.6%
6,4932.255 USD |
4.970 +48.6% | 6,49 | 32.255 USD | |
2020-12-14 | 2020-12-11 |
Evelo Biosciences Inc
(EVLO)
|
K Kauf |
30
+0.3%
6,45194 USD |
30 +0.3% | 6,45 | 194 USD | |
2020-12-14 | 2020-12-11 |
Evelo Biosciences Inc
(EVLO)
|
K Kauf |
200
+2.0%
6,401.280 USD |
200 +2.0% | 6,40 | 1.280 USD | |
2020-09-01 | 2020-08-31 |
Evelo Biosciences Inc
(EVLO)
|
K Kauf |
1.000
+11.1%
4,584.580 USD |
1.000 +11.1% | 4,58 | 4.580 USD | |
2020-09-01 | 2020-08-31 |
Evelo Biosciences Inc
(EVLO)
|
K Kauf |
1.000
+12.5%
4,484.480 USD |
1.000 +12.5% | 4,48 | 4.480 USD | |
2020-09-01 | 2020-08-31 |
Evelo Biosciences Inc
(EVLO)
|
K Kauf |
1.000
+14.3%
4,474.470 USD |
1.000 +14.3% | 4,47 | 4.470 USD | |
2020-09-01 | 2020-08-31 |
Evelo Biosciences Inc
(EVLO)
|
K Kauf |
2.752
+64.8%
4,4612.274 USD |
2.752 +64.8% | 4,46 | 12.274 USD | |
2020-09-01 | 2020-08-28 |
Evelo Biosciences Inc
(EVLO)
|
K Kauf |
3.248
+324.8%
4,4014.291 USD |
3.248 +324.8% | 4,40 | 14.291 USD | |
2020-09-01 | 2020-08-28 |
Evelo Biosciences Inc
(EVLO)
|
K Kauf |
1.000
+inf%
4,344.340 USD |
1.000 +inf% | 4,34 | 4.340 USD | |
2020-05-20 | 2020-05-18 |
Axcella Health Inc
(AXLA)
|
K Kauf |
50.000
+73.4%
4,75237.500 USD |
50.000 +73.4% | 4,75 | 237.500 USD | |
2020-03-19 | 2020-03-17 |
Rubius Therapeutics Inc
(RUBY)
|
K Kauf |
5.000
+0.1%
3,7618.800 USD |
5.000 +0.1% | 3,76 | 18.800 USD | |
2020-03-17 | 2020-03-13 |
Rubius Therapeutics Inc
(RUBY)
|
K Kauf |
5.000
+0.1%
4,0020.000 USD |
5.000 +0.1% | 4,00 | 20.000 USD | |
2020-03-17 | 2020-03-13 |
Rubius Therapeutics Inc
(RUBY)
|
K Kauf |
5.000
+0.1%
3,8219.100 USD |
5.000 +0.1% | 3,82 | 19.100 USD | |
2020-03-02 | 2020-02-28 |
Axcella Health Inc
(AXLA)
|
K Kauf |
2.005
+3.0%
3,757.519 USD |
2.005 +3.0% | 3,75 | 7.519 USD | |
2020-03-02 | 2020-02-27 |
Axcella Health Inc
(AXLA)
|
K Kauf |
12.800
+24.0%
3,6546.720 USD |
12.800 +24.0% | 3,65 | 46.720 USD | |
2019-07-18 | 2019-07-17 |
Axcella Health Inc
(AXLA)
|
K Kauf |
1.000
+3.3%
7,557.550 USD |
1.000 +3.3% | 7,55 | 7.550 USD | |
2019-07-10 | 2019-07-10 |
Axcella Health Inc
(AXLA)
|
K Kauf |
1.322
+4.6%
8,0710.669 USD |
1.322 +4.6% | 8,07 | 10.669 USD | |
2019-07-10 | 2019-07-09 |
Axcella Health Inc
(AXLA)
|
K Kauf |
4.200
+16.9%
8,2434.608 USD |
4.200 +16.9% | 8,24 | 34.608 USD | |
2019-07-10 | 2019-07-08 |
Axcella Health Inc
(AXLA)
|
K Kauf |
274
+1.1%
9,002.466 USD |
274 +1.1% | 9,00 | 2.466 USD | |
2019-07-03 | 2019-07-03 |
Axcella Health Inc
(AXLA)
|
K Kauf |
56
+0.3%
8,99503 USD |
56 +0.3% | 8,99 | 503 USD | |
2019-07-03 | 2019-07-02 |
Axcella Health Inc
(AXLA)
|
K Kauf |
3.500
+22.6%
8,7730.678 USD |
3.500 +22.6% | 8,77 | 30.678 USD | |
2019-07-03 | 2019-07-01 |
Axcella Health Inc
(AXLA)
|
K Kauf |
1.000
+6.9%
8,748.735 USD |
1.000 +6.9% | 8,74 | 8.735 USD | |
2019-07-01 | 2019-06-28 |
Axcella Health Inc
(AXLA)
|
K Kauf |
5.400
+37.0%
10,0454.216 USD |
5.400 +37.0% | 10,04 | 54.216 USD | |
2019-07-01 | 2019-06-27 |
Axcella Health Inc
(AXLA)
|
K Kauf |
100
+0.7%
9,15915 USD |
100 +0.7% | 9,15 | 915 USD | |
2019-06-27 | 2019-06-26 |
Axcella Health Inc
(AXLA)
|
K Kauf |
14.500
+inf%
9,57138.765 USD |
14.500 +inf% | 9,57 | 138.765 USD |